Enroll is our innovative, patient-friendly electronic informed consent and patient
enrollment system for clinical trials.
Mytrus is pioneering patient-centered technologies that
enable people to participate in clinical trials in a
better-informed and more convenient way. Enroll has
been independently proven to improve a patient's
understanding of research studies and is currently
being used by leaders in the pharmaceutical community
to Reinvent Consent™.
Thank you. Your message has been received!
Worldwide sites using Enroll
Enroll IRB approvals
Percentage of big pharma Enroll-ing patients this year
Countries introduced to Enroll in 2013
Enroll enables more cost-effective clinical studies
that start and finish faster and provide better
information, in real-time, for sponsors, sites, and
patients. At a time when bringing a drug to market
can cost up to $1 billion, Mytrus provides
precedent-setting solutions for pharmaceutical and
device makers eager to find more cost-effective
ways to conduct research while improving the
Enroll is a gateway technology that allows critical
disclosure information to be condensed into an
easy-to-understand, digitized format using
animation, interaction, and visual imagery.
Patients can interact with the app, marking terms
and concepts that they want to discuss, completing
easy to use knowledge assessments, and providing
regulatorily compliant signatures to indicate their
Dashboard view of real-time, de-identified study data
Site summaries and statistics
Improved patient retention
Ensures required signatures
Consistency across all sites
Reduced monitoring costs
for Clinical Studies
Quicker study starts
Streamlined patient enrollment
Real-time enrollment statistics
Satisfies IRB, QA, and ethics concerns
Superior Comprehension* for Patients
Better understanding of risks and benefits
Improved learning through animation and visual imagery
Multiple language support
Clear and easy study explanation
* Independent validation study conducted by California Pacific Medical Center Research Institute using Enroll.
It's time for a change.
The informed consent process has not
significantly changed since the legal
inception of the Common Rule over 30
years ago. While clinical research has
been significantly impacted by
technology such as electronic data
capture systems, clinical trial
management systems, and other
automation tools that make the clinical
trial process more efficient, a gap has
emerged as the informed consent step
has remained a highly inefficient paper
process that leaves many patients
feeling more confused than informed and
many sponsors feeling left in the dark
as to what is happening at trial sites.
As a technology innovator, Mytrus has
changed all of that.
"Mytrus has developed a product that
makes the cumbersome, but critical, process of
informed consent simple and efficient for
patients and offers sponsors and regulators new
opportunities to collect and track important
informed consent data analytics."